Product Details

• Product Name: PriGrow™ IV Medium
• Product Type: Medium
• Catalog Number: TM004
• Unit Size: 500 mL
• Formulation: Serum-free and antibiotic-free basal medium
• Appearance: Liquid
• pH Range: 7.0-7.6
• Osmolarity: 287-317 mOsm/kgH₂O
• Endotoxin Level: ≤ 1 EU/mL
• Sterility: Pass
• Storage Condition: 2-8°C
• Shipping Condition: Shipped with cold packs

Overview

PriGrow™ IV Medium is a highly adaptable basal medium formulated for the cultivation of mammalian cells under serum-free and antibiotic-free conditions. This formulation provides a clean and controlled starting point for researchers who require maximum flexibility in customizing their culture environment with specific supplements, growth factors, or antibiotics.
Each production batch undergoes thorough quality control assessments to ensure the consistency and reliability demanded by high-performance research settings.
It is well-suited for a broad range of cell biology workflows, including cell expansion, viability assays, primary cell support, and specialized research studies.

Key Features and Benefits

• Serum- and Antibiotic-Free: Enables full control over supplementation and minimizes background variables in experiments.
• Broad Compatibility: Validated across multiple mammalian cell lines for consistent performance.
• Stringent Quality Standards: Tested for sterility, pH, osmolality, and endotoxin to meet high QC benchmarks.
• Customizable: Ideal for further optimization with user-defined supplements.
• Batch-to-Batch Reliability: Ensures reproducibility for sensitive or long-term experiments.

Key Ingredients and Special Additives

• D-Glucose: 3.15 mM
• CaCl₂: 1 mM

Quality Control (QC)

Every batch of PriGrow™ IV Medium is evaluated using a standardized testing protocol that includes:

• Cell Culture Performance: Assessed for adherence rate (where applicable), characteristic morphology, and metabolic activity using validated cell lines.
• Sterility Testing: Ensures the product is free from microbial, yeast, or fungal contamination.
• Physicochemical Properties: pH and osmolality are measured to meet defined physiological ranges for optimal cell environment.
• Endotoxin Screening: Verifies that endotoxin levels are ≤ 1 EU/mL to maintain suitability for sensitive or primary cells.

Caution

For research use only. This product is not intended for use in therapeutic, diagnostic, or clinical applications. Not for use in humans.

Disclaimer

1. This product is intended strictly for laboratory research purposes.
2. No warranty is made regarding the accuracy or completeness of product performance beyond its specified application.
3. Any cited references are for informational use only and do not imply validation or endorsement.

References

1. Prabhu, Antony, et al. “Targeting the unfolded protein response in glioblastoma cells with the fusion protein EGF-SubA.” PLoS One 7.12 (2012): e52265.
2. Erkan, E. P., et al. “Depletion of minichromosome maintenance protein 7 inhibits glioblastoma multiforme tumor growth in vivo.” Oncogene 33.39 (2014): 4778-4785.
3. Soo Kim, Beob, et al. “Human collagen‐based multilayer scaffolds for tendon‐to‐bone interface tissue engineering.” Journal of Biomedical Materials Research Part A 102.11 (2014): 4044-4054.
4. Deep, Gagan, et al. “Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling.” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 768 (2014): 35-46.
5. Schlaepfer, Isabel R., et al. “Inhibition of lipid oxidation increases glucose metabolism and enhances 2-deoxy-2-[18 F] Fluoro-d-glucose uptake in prostate cancer mouse xenografts.” Molecular Imaging and Biology 17 (2015): 529-538.
6. Dozio, Vito, and Jean-Charles Sanchez. “Profiling the proteomic inflammatory state of human astrocytes using DIA mass spectrometry.” Journal of neuroinflammation 15 (2018): 1-14.
7. Gutkin, Dmitriy W., et al. “Novel protein and immune response markers of human serous tubal intraepithelial carcinoma of the ovary.” Cancer Biomarkers 26.4 (2019): 471-479.